{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:55:32Z","timestamp":1760061332194,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94235","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T22:52:59Z","timestamp":1760050379000},"source":"Crossref","is-referenced-by-count":0,"title":["Intertumoral Heterogeneity in Multifocal Breast Cancer Mimicking a Collision Tumor on Imaging: A Case Report"],"prefix":"10.7759","author":[{"given":"Yoshika","family":"Nagata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiji","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2217","article-title":"Intratumor heterogeneity: evolution through space and time","volume":"72","author":"Swanton C","year":"2012","unstructured":"Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012, 72:4875-82. 10.1158\/0008-5472.CAN-12-2217","journal-title":"Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60534","article-title":"Heterogeneity in breast cancer","volume":"121","author":"Polyak K","year":"2011","unstructured":"Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011, 121:3786-8. 10.1172\/JCI60534","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14236","article-title":"Collision tumors: a review of their types, pathogenesis, and diagnostic challenges","volume":"33","author":"Bulte CA","year":"2020","unstructured":"Bulte CA, Hoegler KM, Khachemoune A. Collision tumors: a review of their types, pathogenesis, and diagnostic challenges. Dermatol Ther. 2020, 33:e14236. 10.1111\/dth.14236","journal-title":"Dermatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2015.02.001","article-title":"Chronic lymphocytic leukemia and invasive ductal carcinoma presenting as a collision breast tumor","volume":"15","author":"Jafarian N","year":"2015","unstructured":"Jafarian N, Kuppler K, Rosa M, Hoover S, Patel B. Chronic lymphocytic leukemia and invasive ductal carcinoma presenting as a collision breast tumor. Clin Breast Cancer. 2015, 15:e209-12. 10.1016\/j.clbc.2015.02.001","journal-title":"Clin Breast Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155100","article-title":"Malignant phyllodes tumor and invasive lobular breast carcinoma: morpho-molecular characterization of an uncommon collision tumor and review of the literature","volume":"254","author":"Schaumann N","year":"2024","unstructured":"Schaumann N, Bartels S, Kuehnle E, Kreipe H, Christgen M. Malignant phyllodes tumor and invasive lobular breast carcinoma: morpho-molecular characterization of an uncommon collision tumor and review of the literature. Pathol Res Pract. 2024, 254:155100. 10.1016\/j.prp.2024.155100","journal-title":"Pathol Res Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00156","article-title":"Editorial: tumor heterogeneity","volume":"6","author":"La Rosa S","year":"2019","unstructured":"La Rosa S, Rubbia-Brandt L, Scoazec JY, Weber A. Editorial: tumor heterogeneity. Front Med (Lausanne). 2019, 6:156. 10.3389\/fmed.2019.00156","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00109.2021","article-title":"Heterogeneity within molecular subtypes of breast cancer","volume":"321","author":"Turner KM","year":"2021","unstructured":"Turner KM, Yeo SK, Holm TM, Shaughnessy E, Guan JL. Heterogeneity within molecular subtypes of breast cancer. Am J Physiol Cell Physiol. 2021, 321:C343-54. 10.1152\/ajpcell.00109.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15154005","article-title":"Emerging role of epigenetic modifiers in breast cancer pathogenesis and therapeutic response","volume":"15","author":"Lee RS","year":"2023","unstructured":"Lee RS, Sad K, Fawwal DV, Spangle JM. Emerging role of epigenetic modifiers in breast cancer pathogenesis and therapeutic response. Cancers (Basel). 2023, 15:4005. 10.3390\/cancers15154005","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801215)46:12<2702::aid-cncr2820461228>3.0.co;2-m","article-title":"Collision carcinoma at the esophagogastric junction: report of two cases","volume":"46","author":"Spagnolo DV","year":"1980","unstructured":"Spagnolo DV, Heenan PJ. Collision carcinoma at the esophagogastric junction: report of two cases. Cancer. 1980, 46:2702-8. 10.1002\/1097-0142(19801215)46:12&lt;2702::aid-cncr2820461228&gt;3.0.co;2-m","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2020.09.03","article-title":"Imaging features of breast cancer molecular subtypes: state of the art","volume":"55","author":"Cho N","year":"2021","unstructured":"Cho N. Imaging features of breast cancer molecular subtypes: state of the art. J Pathol Transl Med. 2021, 55:16-25. 10.4132\/jptm.2020.09.03","journal-title":"J Pathol Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140594","article-title":"Can breast cancer molecular subtype help to select patients for preoperative MR imaging?","volume":"274","author":"Grimm LJ","year":"2015","unstructured":"Grimm LJ, Johnson KS, Marcom PK, Baker JA, Soo MS. Can breast cancer molecular subtype help to select patients for preoperative MR imaging?. Radiology. 2015, 274:352-8. 10.1148\/radiol.14140594","journal-title":"Radiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2010.09.012","article-title":"Paired distribution of molecular subtypes in bilateral breast carcinomas","volume":"204","author":"Russnes HG","year":"2011","unstructured":"Russnes HG, Kuligina ESh, Suspitsin EN, et al.. Paired distribution of molecular subtypes in bilateral breast carcinomas. Cancer Genet. 2011, 204:96-102. 10.1016\/j.cancergencyto.2010.09.012","journal-title":"Cancer Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.2482","article-title":"Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression","volume":"30","author":"Lindstr\u00f6m LS","year":"2012","unstructured":"Lindstr\u00f6m LS, Karlsson E, Wilking UM, et al.. Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol. 2012, 30:2601-8. 10.1200\/JCO.2011.37.2482","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5626","article-title":"Multifocal\/multicentric breast cancer: does each focus matter?","volume":"12","author":"Tong Y","year":"2023","unstructured":"Tong Y, Sun F, Zhang C, Yang S, Yu Z, Zhao Y. Multifocal\/multicentric breast cancer: does each focus matter?. Cancer Med. 2023, 12:8815-24. 10.1002\/cam4.5626","journal-title":"Cancer Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.155","article-title":"Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers","volume":"6","author":"McCrorie AD","year":"2020","unstructured":"McCrorie AD, Ashfield S, Begley A, et al.. Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers. J Pathol Clin Res. 2020, 6:146-53. 10.1002\/cjp2.155","journal-title":"J Pathol Clin Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418259-intertumoral-heterogeneity-in-multifocal-breast-cancer-mimicking-a-collision-tumor-on-imaging-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T22:53:00Z","timestamp":1760050380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418259-intertumoral-heterogeneity-in-multifocal-breast-cancer-mimicking-a-collision-tumor-on-imaging-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.94235","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}